PARLIAMENTARY WRITTEN QUESTION
Drugs: Licensing (11 December 2014)
Question Asked
Asked by:
Kerry McCarthy (Labour)
Answer
In developing our response to the Off-patent Drugs Bill, we have taken advice from clinicians and officials at NHS England, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations. We will be discussing a number of issues the Bill raises at a roundtable stakeholder event in the new year and we plan to invite a number of general practitioner representatives.
Answered by:
George Freeman (Conservative)
18 December 2014
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.